May 19, 2021 – Holborn Wells, is a leading healthcare focused company established in UK since 2013 which delivers innovative and AI driven solutions for key industry sectors especially healthcare. The company has established a business unit in Delhi, India that will be supported by Holborn Wells technical partners based in European Union and local partners bringing together innovative and affordable IVD product for Indian market.
Holborn Wells India has initiated the regulatory process with CDSCO india, and will strive to establish itself as the leading provider of Molecular Diagnostics products in the Indian market. The company has appointed Mr. Sudhanshu Srivastava as a new CEO for the Indian and Asian markets. Mr Srivastava brings over 25+ years of experience of the industry and previously was the business unit head at Eurofins India.
According to Mr Srivastava, “India is a key market for us and we aim to provide innovative and affordable diagnostics solutions for the market. Our designs are highly sophisticated with superior quality reagents that provide consistency and enhanced quality control. Our company Holbornwells.com has the vision to become the global leader in providing Molecular Diagnostics products for affordable solutions for infectious disease globally.”
Holborn Wells spokesman said “We see the new Holborn Wells manufacturing base in India as being an important step towards the positive impact molecular diagnostics can have in the region over the next decade considering the Indian Government’s ‘Made in India’ initiative will see the nation emerge as a major player in the provision of quality IVD products in a global supply chain.”
Holborn Wells India intends to launch a portfolio of over 150 IVD products to market within the next year.
About Holborn Wells
Holborn Wells is a leading UK based Data and AI company focused on healthcare since 2013. company recently established its IVD business unit in India.
For more details, please visit https://www.holbornwells.com/